A detailed history of Altrius Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Altrius Capital Management Inc holds 25,873 shares of ABBV stock, worth $4.27 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
25,873
Previous 26,014 0.54%
Holding current value
$4.27 Million
Previous $4.46 Million 14.53%
% of portfolio
1.31%
Previous 1.2%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $23,101 - $28,105
-141 Reduced 0.54%
25,873 $5.11 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $224,909 - $262,644
1,453 Added 5.92%
26,014 $4.46 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $228,702 - $260,585
1,431 Added 6.19%
24,561 $4.47 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $59,305 - $66,792
431 Added 1.9%
23,130 $3.58 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $71,737 - $83,047
537 Added 2.42%
22,699 $3.38 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $83,613 - $104,051
631 Added 2.93%
22,162 $2.99 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $114,675 - $132,066
793 Added 3.82%
21,531 $3.43 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $140,108 - $168,026
-1,013 Reduced 4.66%
20,738 $3.35 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $2.04 Million - $2.34 Million
-15,224 Reduced 41.17%
21,751 $2.92 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $5.09 Million - $6.47 Million
36,975 New
36,975 $5.66 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Altrius Capital Management Inc Portfolio

Follow Altrius Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrius Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altrius Capital Management Inc with notifications on news.